Families across five continents reveal their daily struggle against ultra-processed foods targeting children. New Lancet study warns of long-term health harms as obesity rates soar. Read their stories.
With up to 65% of British dogs overweight, a new trial tests 'Ozempic' style jabs for cats and dogs. Could this revolutionise pet health or dampen their joy?
The World Health Organization has issued its first conditional recommendation for weight loss injections to treat obesity, a condition affecting over a billion people globally. Read the latest on access and NHS rollout.
The WHO urges global access to GLP-1 therapies like Mounjaro, calling them a breakthrough in treating obesity, a disease affecting 2 billion by 2030.
The UK government announces milkshakes will no longer be exempt from the sugar tax as part of strengthened measures to tackle childhood obesity. Learn how this affects your favourite drinks.
Health Secretary Wes Streeting announces the soft drinks levy will expand to include milkshakes and milk substitutes to tackle childhood obesity. Read the latest.
New research reveals discontinuing the weight-loss jab Mounjaro leads to significant weight regain and a reversal of cardiometabolic benefits. Learn why long-term treatment may be crucial.
Investigation reveals Nestlé adds up to 7.5g sugar per serving to baby cereals in Africa while European products remain sugar-free. Campaigners accuse company of health risks.
A new study reveals high blood pressure in children has nearly doubled since 2000, now affecting 6.2% of under-19s. Experts call for urgent government action on childhood obesity.
Global study reveals childhood hypertension rates have nearly doubled since 2000, with obesity identified as primary driver. Experts warn of lifelong health consequences.
Shocking new NHS data reveals obesity levels in young children have reached their highest point outside of pandemic years, with stark inequalities between wealthy and deprived areas.
Great British Bake Off star Dame Prue Leith reveals her dramatic change of heart about weight loss injections, warning they're not the miracle solution many believe.
New research reveals how declining public health is creating a ticking time bomb for UK businesses, with rising obesity and inactivity levels threatening productivity and economic growth.
Danish pharmaceutical giant Novo Nordisk has entered a bidding war with Pfizer for obesity-focused biotech firm Metsera, potentially disrupting the US company's planned acquisition in a major power play for obesity treatment dominance.